Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy

Table 2

Changes of fibrillation potential amplitudes and muscle fibers following treatments.

	Clenbuterol	Placebo
Decrease in cross-sectional areas of type I fibers, μm^2	413 ± 91.7	687.1 ± 84.6	𝑃=0.038
Decrease in cross-sectional areas of type II fibers, μm^2	512.1 ± 75.1	821.3 ± 118.7	𝑃=0.045
Reduction in fibrillation potential amplitude, μV	57.3 ± 32.7	231.5 ± 56.6	𝑃=0.013

Figures are means ± standard errors.